Literature DB >> 27146752

Increasing incidence of adenocarcinoma lung in India: Following the global trend?

A Mohan1, A N Latifi, R Guleria.   

Abstract

BACKGROUND: Lung cancer is one of the most common malignant neoplasms worldwide and accounts for more deaths than any other cancer. The clinicopathological profile of lung cancer has shown marked regional and geographical variation. AIMS: We aimed to compare the demographic and pathological profile of lung cancer patients from North India with other Indian and International series. SETTING AND
DESIGN: A retrospective study over a period of 5 years from January 2008 to May 2013 was conducted in the Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences, New Delhi. PATIENTS AND METHODS: A total of 397 newly diagnosed patients with lung cancer from January 2008 to May 2013 were included in the study. The clinical, demographic, and pathological features were reviewed and compared with other major National and International reports. Data were entered and analyzed using SPSS software (SPSS Inc. Released 2009. PASW Statistics for Windows, Version 18.0. Chicago: SPSS Inc.
RESULTS: A total of 397 patients (86% men, mean age 57.8 years) were studied. The ratio of men to women was 7.4. Majority of patients (78.3%) were current/previous smokers. Small cell carcinoma was diagnosed in 14.6% (58) of patients while 85.4% (339) had nonsmall cell lung carcinoma (NSCLC). Within NSCLC, the most common histology types were squamous cell carcinoma (30%), followed closely by adenocarcinoma (ADC) (28.3%) and large cell carcinoma (1.7%). Majority (87%) of the patient were staged III and IV. About 30.1% patients received anti-tubercular treatment during the current episode before a diagnosis of lung cancer was made.
CONCLUSION: The clinicopathological profile of lung cancer has undergone noticeable changes over the last four decades, especially in the increase in ADC incidence and their frequent presence in smokers. Lung cancer is often mistreated as tuberculosis in the Indian subcontinent and hence continues to be diagnosed late.

Entities:  

Mesh:

Year:  2016        PMID: 27146752     DOI: 10.4103/0019-509X.180819

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  5 in total

1.  Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing.

Authors:  Kumar Prabhash; Suresh H Advani; Ullas Batra; Bivas Biswas; Anuradha Chougule; Mithua Ghosh; Vamshi Krishna Muddu; T P Sahoo; Ashok K Vaid
Journal:  Adv Ther       Date:  2019-03-12       Impact factor: 3.845

2.  Comparison of Detection of Epidermal Growth Factor Receptor (EFGR) Gene Mutation in Peripheral Blood Plasma (Liquid Biopsy) with Cytological Specimens in Lung Adenocarcinoma Patients.

Authors:  Laksmi Wulandari; Gatot Soegiarto; Anna Febriani; Farah Fatmawati
Journal:  Indian J Surg Oncol       Date:  2020-02-05

3.  Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center.

Authors:  Anant Mohan; Avneet Garg; Aditi Gupta; Satyaranjan Sahu; Chandrashekhar Choudhari; Vishal Vashistha; Ashraf Ansari; Rambha Pandey; Ashu Seith Bhalla; Karan Madan; Vijay Hadda; Hariharan Iyer; Deepali Jain; Rakesh Kumar; Saurabh Mittal; Pawan Tiwari; Ravindra M Pandey; Randeep Guleria
Journal:  Lung India       Date:  2020 May-Jun

4.  Challenges in the Management of Lung Cancer: Real-World Experience from a Tertiary Center in South India.

Authors:  Vishnu Gopal; Biswajit Dubashi; Smita Kayal; Prasanth Penumadu; Manju Rajaram; Gunaseelan Karunanithi; Subathra Adithan; Pampa Ch Toi; Prasanth Ganesan
Journal:  South Asian J Cancer       Date:  2021-12-20

5.  Current Trends of Carcinoma: Experience of a Tertiary Care Cancer Center in North India.

Authors:  Manjit K Rana; Tushar S Barwal; Uttam Sharma; Richika Bansal; Karuna Singh; Amrit Pal S Rana; Aklank Jain; Utkarshni Khera
Journal:  Cureus       Date:  2021-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.